Susquehanna International Group
AMPE

Susquehanna International Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Susquehanna International Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-206
Closed -$10K – 14693
2022
Q2 		$10K Sell
206
-175
-46% -$13K ﹤0.01% 12520
2022
Q1 		$54K Sell
381
-32
-8% -$4.67K ﹤0.01% 12281
2021
Q4 		$71K Buy
413
+243
+143% +$90.6K ﹤0.01% 12374
2021
Q3 		$85K Sell
170
-407
-71% -$189K ﹤0.01% 12155
2021
Q2 		$289K Sell
577
-367
-39% -$197K ﹤0.01% 10841
2021
Q1 		$479K Sell
944
-1,229
-57% -$634K ﹤0.01% 9580
2020
Q4 		$1.04M Buy
2,173
+1,673
+335% +$549K ﹤0.01% 6644
2020
Q3 		$144K Buy
500
+407
+438% +$101K ﹤0.01% 9713
2020
Q2 		$18K Sell
93
-22
-19% -$3.66K ﹤0.01% 9935
2020
Q1 		$14K Buy
+115
New +$20.8K ﹤0.01% 10006
2018
Q4 		– Sell
-107
Closed -$16K – 10300
2018
Q3 		$16K Sell
107
-146
-58% -$61K ﹤0.01% 9020
2018
Q2 		$167K Sell
253
-44
-15% -$32.9K ﹤0.01% 8778
2018
Q1 		$303K Sell
297
-465
-61% -$389K ﹤0.01% 7619
2017
Q4 		$930K Buy
+762
New +$358K ﹤0.01% 5386
2017
Q3 		– Sell
-86
Closed -$13K – 9888
2017
Q2 		$13K Buy
86
+10
+13% +$2.02K ﹤0.01% 9060
2017
Q1 		$18K Buy
+76
New +$20.4K ﹤0.01% 8746
2016
Q3 		– Sell
-91
Closed -$35K – 9254
2016
Q2 		$35K Sell
91
-39
-30% -$42.6K ﹤0.01% 8301
2016
Q1 		$88K Sell
130
-341
-72% -$230K ﹤0.01% 8484
2015
Q4 		$495K Buy
471
+144
+44% +$143K ﹤0.01% 6789
2015
Q3 		$284K Buy
327
+6
+2% +$5.02K ﹤0.01% 8132
2015
Q2 		$243K Sell
321
-333
-51% -$355K ﹤0.01% 8944
2015
Q1 		$1.48M Buy
654
+316
+93% +$539K ﹤0.01% 4953
2014
Q4 		$348K Sell
338
-124
-27% -$132K ﹤0.01% 7884
2014
Q3 		$489K Sell
462
-770
-63% -$1.3M ﹤0.01% 7256
2014
Q2 		$3.09M Buy
1,232
+487
+65% +$994K ﹤0.01% 3870
2014
Q1 		$1.42M Buy
745
+641
+616% +$1.52M ﹤0.01% 4896
2013
Q4 		$223K Buy
104
+30
+41% +$70.9K ﹤0.01% 8078
2013
Q3 		$167K Buy
74
+8
+12% +$15.5K ﹤0.01% 7873
2013
Q2 		$115K Buy
+66
New +$105K ﹤0.01% 7735

Other funds holding AMPE

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's AMPE Position: Q1 2024 in Review

Susquehanna International Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2024, closing a stake of 19,580 shares — an estimated $40.1K sold.

Susquehanna International Group first reported a position in AMPE in Q3 2013 and held it in 32 quarters. The position peaked at $3.18M in Q3 2013. 28 funds tracked by Wall St. Rank hold AMPE as of Q1 2024.

  • Susquehanna International Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 19,580 Ampio Pharmaceuticals Inc. shares in Q1 2024, an estimated $40.1K.
  • Susquehanna International Group first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 32 quarters.
  • Susquehanna International Group's Ampio Pharmaceuticals Inc. position peaked at $3.18M in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.